CMS-Blessed Warfarin Genetic Testing Trial Aimed At Winning Over Payers and Docs

Genetic testing to guide dosing of warfarin is still relevant, even with new competing oral anticoagulants on the rise, says the CEO of Iverson, the diagnostics company sponsoring the trial.